U.S. markets open in 9 hours 9 minutes
  • S&P Futures

    3,672.25
    +7.75 (+0.21%)
     
  • Dow Futures

    29,986.00
    +54.00 (+0.18%)
     
  • Nasdaq Futures

    12,500.50
    +38.25 (+0.31%)
     
  • Russell 2000 Futures

    1,850.30
    +3.10 (+0.17%)
     
  • Crude Oil

    46.42
    +0.78 (+1.71%)
     
  • Gold

    1,843.90
    +2.80 (+0.15%)
     
  • Silver

    24.19
    +0.06 (+0.24%)
     
  • EUR/USD

    1.2146
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    0.9200
    -0.0280 (-2.95%)
     
  • Vix

    21.28
    +0.11 (+0.52%)
     
  • GBP/USD

    1.3445
    -0.0007 (-0.06%)
     
  • USD/JPY

    103.9200
    +0.0600 (+0.06%)
     
  • BTC-USD

    19,314.16
    +56.58 (+0.29%)
     
  • CMC Crypto 200

    379.31
    +4.90 (+1.31%)
     
  • FTSE 100

    6,490.27
    +26.88 (+0.42%)
     
  • Nikkei 225

    26,740.20
    -69.17 (-0.26%)
     

Aerie: 3Q Earnings Snapshot

·1 min read

NORTH CAROLINA, N.C. (AP) _ Aerie Pharmaceuticals Inc. (AERI) on Thursday reported a loss of $39.6 million in its third quarter.

On a per-share basis, the North Carolina, North Carolina-based company said it had a loss of 86 cents. Losses, adjusted for non-recurring costs, were 65 cents per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 81 cents per share.

The drugmaker posted revenue of $20.1 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $19.2 million.

Aerie shares have declined 56% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $10.73, a drop of 55% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AERI at https://www.zacks.com/ap/AERI